| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Urology and Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine Baltimore, Maryland 21205
Address requests for reprints to: Dr. Donald S. Coffey, Departments of Urology and Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Marburg 113,600 North Wolfe Street, Baltimore, Maryland 21205.
Abstract
The DNA of interphase nuclei have very specific three-dimensional organizations that are different in different cell types, and it is possible that this varying ONA organization is responsible for the tissue specificity of gene expression. The nuclear matrix organizes the three-dimensional structure of the DNA and is believed to be involved in the control of gene expression. This study compares the nuclear structural proteins between two sex accessory tissues in the same animal responding to the same androgen stimulation by the differential expression of major tissue-specific secretory proteins.
We demonstrate here that the nuclear matrix is tissue specific in the rat ventral prostate and seminal vesicle, and undergoes characteristic alterations in its protein composition upon androgen withdrawal. Three types of nuclear matrix proteins were observed: 1) nuclear matrix proteins that are different and tissue specific in the rat ventral prostate and seminal vesicle, 2) a set of nuclear matrix proteins that either appear or disappear upon androgen withdrawal, and 3) a set of proteins that are common to both the ventral prostate and seminal vesicle and do not change with the hormonal state of the animal. Since the nuclear matrix is known to bind androgen receptors in a tissue- and steroid-specific manner, we propose that the tissue specificity of the nuclear matrix arranges the DNA in a unique conformation, which may be involved in the specific interaction of transcription factors with DNA sequences, resulting in tissue-specific patterns of secretory protein expression.
FOOTNOTES
This work was supported by HHS NIDDKD Grant DK- 22000.
Received for publication April 20, 1990. Revision received May 23, 1990. Accepted for publication May 23, 1990.
This article has been cited by other articles:
![]() |
D. S. Coffey, R. H. Getzenberg, and T. L. DeWeese Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect". JAMA, July 26, 2006; 296(4): 445 - 448. [Full Text] [PDF] |
||||
![]() |
M. Balasubramani, B. W. Day, R. E. Schoen, and R. H. Getzenberg Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon Cancer Cancer Res., January 15, 2006; 66(2): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Zaidi, A. Javed, J.-Y. Choi, A. J. van Wijnen, J. L. Stein, J. B. Lian, and G. S. Stein A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene J. Cell Sci., January 9, 2001; 114(17): 3093 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Townson, T. Sullivan, Q. Zhang, G. M. Clark, C. K. Osborne, A. V. Lee, and S. Oesterreich HET/SAF-B Overexpression Causes Growth Arrest and Multinuclearity and Is Associated with Aneuploidy in Human Breast Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3788 - 3796. [Abstract] [Full Text] |
||||
![]() |
B. R. Konety, T.-S. T. Nguyen, R. Dhir, R. S. Day, M. J. Becich, W. M. Stadler, and R. H. Getzenberg Detection of Bladder Cancer Using a Novel Nuclear Matrix Protein, BLCA-4 Clin. Cancer Res., July 1, 2000; 6(7): 2618 - 2625. [Abstract] [Full Text] |
||||
![]() |
L. Yang, J. Guerrero, H. Hong, D. B. DeFranco, and M. R. Stallcup Interaction of the tau 2 Transcriptional Activation Domain of Glucocorticoid Receptor with a Novel Steroid Receptor Coactivator, Hic-5, Which Localizes to Both Focal Adhesions and the Nuclear Matrix Mol. Biol. Cell, June 1, 2000; 11(6): 2007 - 2018. [Abstract] [Full Text] |
||||
![]() |
G. S. Stein, M. Montecino, A. J. van Wijnen, J. L. Stein, and J. B. Lian Nuclear Structure-Gene Expression Interrelationships: Implications for Aberrant Gene Expression in Cancer Cancer Res., April 1, 2000; 60(8): 2067 - 2076. [Abstract] [Full Text] |
||||
![]() |
S. Oesterreich, Q. Zhang, T. Hopp, S. A. W. Fuqua, M. Michaelis, H. H. Zhao, J. R. Davie, C. K. Osborne, and A. V. Lee Tamoxifen-Bound Estrogen Receptor (ER) Strongly Interacts with the Nuclear Matrix Protein HET/SAF-B, a Novel Inhibitor of ER-Mediated Transactivation Mol. Endocrinol., March 1, 2000; 14(3): 369 - 381. [Abstract] [Full Text] |
||||
![]() |
G.-S. Yoon, H. Lee, Y. Jung, E. Yu, H.-B. Moon, K. Song, and I. Lee Nuclear Matrix of Calreticulin in Hepatocellular Carcinoma Cancer Res., February 1, 2000; 60(4): 1117 - 1120. [Abstract] [Full Text] |
||||
![]() |
G. S. STEIN, A. J. VAN WIJNEN, J. L. STEIN, J. B. LIAN, S. H. POCKWINSE, and S. MCNEIL Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions FASEB J, May 1, 1999; 13(9001): 157 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raziuddin, D. Court, F. H. Sarkar, Y.-L. Liu, H.-f. Kung, and R. Raziuddin A c-erbB-2 Promoter-specific Nuclear Matrix Protein from Human Breast Tumor Tissues Mediates NF-kappa B DNA Binding Activity J. Biol. Chem., June 20, 1997; 272(25): 15715 - 15720. [Abstract] [Full Text] [PDF] |
||||
![]() |
B van Steensel, M Brink, K van der Meulen, E. van Binnendijk, D. Wansink, L de Jong, E. de Kloet, and R van Driel Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus J. Cell Sci., January 9, 1995; 108(9): 3003 - 3011. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |